Key result
LMWH manages right adrenal infarction secondary to elevated factor VIII during pregnancy.
Why the study?
Adrenal infarction in pregnancy is an extremely rare event that requires clinical suspicion especially with unexplained acute abdominal pain and thrombophilia.
Case Report (n=1)
Highlights the importance of suspecting adrenal infarction in pregnant women with unexplained acute abdominal pain and suggestive radiological findings, particularly with underlying thrombophilia.
Answers are grounded in this paper and cite their sources.
Adrenal infarction warrants consideration in pregnant patients with acute right upper quadrant pain; this case leaves open the need for systematic data on this rare condition.
Adrenal infarction in pregnancy is an extremely rare event. We report a case of a 29-year-old pregnant woman at the twenty-fourth week of gestation that presented with an acute episode of severe localized right upper quadrant pain. Her preliminary blood investigations and abdominal ultrasonography were essentially unremarkable. A diagnosis of right adrenal infarction was subsequently established on the basis of a non-enhanced swollen right adrenal gland on CT scanning of the abdomen with contrast, consistent with the clinical presentation. She was treated with subcutaneous low molecular weight heparin (LMWH) until 2 weeks postpartum. A thrombophilia screen post-partum revealed a significantly elevated factor VIII level and a hypercoagulable state that justified prolonged anticoagulation. This case highlights the importance of a high index of suspicion for adrenal infarction in pregnancy on the clinical grounds of otherwise unexplained acute abdominal pain accompanied by suggestive radiological findings, especially in the presence of thrombophilia.
No takes yet. Share an insight, caveat, or question.
Aljenaee et al. (2017) conducted a case report in Adrenal infarction in pregnancy (n=1). Low molecular weight heparin (LMWH) was evaluated. A 29-year-old pregnant woman with right adrenal infarction secondary to elevated factor VIII was managed with low molecular weight heparin until 2 weeks postpartum.
Synapse has enriched 10 related papers. Consider them for comparative context: